"Over 100 new patent complaints were filed in the district court, with 64 cases terminated, mostly through file-and-settle agreements, indicating a high level of litigation activity."
"Intel and Xilinx canceled several litigation-funded chip patents, while Fortress Biotech's subsidiaries are involved in complex pharmaceutical patent challenges, showcasing the intricate nature of patent disputes."
"WePay has expanded its design patent campaign to target major online payment providers, reflecting the ongoing evolution and competitive landscape in patent litigation."
The district court experienced a busy week with over 100 new patent complaints filed and 64 cases terminated, primarily through settlements. The Patent Trial and Appeal Board saw an average of 26 cases, with no denials related to Fintiv. Notable litigation included Intel and Xilinx canceling litigation-funded chip patents, while Fortress Biotech's subsidiaries engaged in various pharmaceutical patent challenges. WePay also expanded its design patent campaign targeting major online payment providers, indicating ongoing trends in patent litigation across multiple sectors.
Read at IPWatchdog.com | Patents & Intellectual Property Law
Unable to calculate read time
Collection
[
|
...
]